Archive for September, 2022

  • Isofol reports data from the AGENT study

    GOTHENBURG, Sweden, 7 september 2022 - Isofol Medical AB (publ), (Nasdaq Stockholm: ISOFOL) today reported data from the AGENT study…

    by